Free Trial
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel Free RYTM Stock Alerts

Rhythm Pharmaceuticals (RYTM) Short Interest Ratio & Short Volume

Rhythm Pharmaceuticals logo
$89.72 +0.02 (+0.02%)
Closing price 04:00 PM Eastern
Extended Trading
$89.64 -0.08 (-0.08%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Rhythm Pharmaceuticals Short Interest Overview

As of May 29, 2026, Rhythm Pharmaceuticals (RYTM) had a short interest of 7.91 million shares sold short, representing 12.27% of the public float. This marks a -4.48% decrease in short interest since the prior report. The short interest ratio (days to cover) is 14.8, meaning it would take 14.8 days of the average trading volume of 594,696 shares to cover all short positions.

Current Short Interest
7,911,004 shares
Previous Short Interest
8,282,367 shares
Change Vs. Previous Month
-4.48%
Dollar Volume Sold Short
$698.70 million
Short Interest Ratio
14.8 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
68,530,000 shares
Short Percent of Float
12.27%
Today's Trading Volume
609,535 shares
Average Trading Volume
594,696 shares
Today's Volume Vs. Average
102%
Short Selling Rhythm Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

RYTM Short Interest Over Time

RYTM Days to Cover Over Time

RYTM Percentage of Float Shorted Over Time

Rhythm Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/20267,911,004 shares $698.70 million -4.5%12.3%14.78 $88.32
5/15/20268,282,367 shares $749.72 million +2.8%12.8%8.28 $90.52
4/30/20268,057,652 shares $655.57 million +2.9%12.5%14.55 $81.36
4/15/20267,830,912 shares $687.63 million +2.7%12.2%12.81 $87.81
3/31/20267,624,913 shares $663.14 million +16.7%11.9%5.93 $86.97
3/13/20266,535,847 shares $571.10 million +3.4%10.2%7.59 $87.38
2/27/20266,321,762 shares $586.22 million +5.0%9.9%9.1 $92.73
2/13/20266,022,578 shares $590.63 million -3.5%9.6%7.9 $98.07
1/30/20266,237,463 shares $639.46 million -0.8%10.0%11.8 $102.52
1/15/20266,285,002 shares $666.59 million +1.4%10.0%9.87 $106.06
12/31/20256,200,378 shares $663.69 million +11.1%9.9%8.04 $107.04
12/15/20255,581,124 shares $627.99 million +1.1%8.9%4.98 $112.52
11/28/20255,518,605 shares $620.95 million +0.3%8.8%8.53 $112.52
11/14/20255,502,046 shares $546.96 million +5.2%8.8%7 $99.41
10/31/20255,230,596 shares $595.03 million -6.2%8.4%9.24 $113.76
10/15/20255,570,000 shares $609.08 million -0.2%8.9%9.5 $109.35
9/30/20255,580,000 shares $563.52 million +6.9%N/A8.8 $100.99
9/15/20255,220,000 shares $501.28 million +5.0%N/A7.2 $96.03
8/31/20254,970,000 shares $512.66 million +6.4%8.0%7 $103.15
8/15/20254,670,000 shares $455.84 million +3.6%N/A6.7 $97.61
7/31/20254,510,000 shares $384.39 million -5.9%7.2%6.3 $85.23
7/15/20254,790,000 shares $428.03 million -1.2%N/A6.5 $89.36
6/30/20254,850,000 shares $306.47 million +1.9%8.1%5.8 $63.19
6/15/20254,760,000 shares $299.40 million -0.4%8.0%6.7 $62.90
5/31/20254,780,000 shares $293.30 million -5.7%8.2%6.7 $61.36
5/15/20255,070,000 shares $305.11 million +4.5%8.7%6.9 $60.18
4/30/20254,850,000 shares $316.17 million -5.1%N/A7 $65.19
4/15/20255,110,000 shares $317.28 million +9.7%8.8%7.8 $62.09
3/31/20254,660,000 shares $246.84 million -1.1%8.0%7.4 $52.97
3/15/20254,710,000 shares $240.07 million -8.5%8.1%8.9 $50.97
2/28/20255,150,000 shares $282.78 million -4.8%8.9%9.8 $54.91
2/15/20255,410,000 shares $306.69 million +5.5%9.3%10.7 $56.69
1/31/20255,130,000 shares $304.88 million -5.9%N/A8.8 $59.43
1/15/20255,450,000 shares $292.45 million +3.4%N/A9.4 $53.66
12/31/20245,270,000 shares $295.01 million -9.3%N/A9.7 $55.98
12/15/20245,810,000 shares $320.94 million -8.8%N/A11.4 $55.24
11/30/20246,370,000 shares $395.19 million -5.1%N/A12.3 $62.04
11/15/20246,710,000 shares $377.30 million -19.7%N/A13.5 $56.23
10/31/20248,360,000 shares $399.02 million -1.2%N/A18.3 $47.73
10/15/20248,460,000 shares $426.47 million +2.8%N/A21.6 $50.41
How to play the Biggest IPO in stock market history! (Ad)

SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.tc pixel

Get all five tickers now, completely free
9/30/20248,230,000 shares $431.17 million -11.9%N/A19.1 $52.39
9/15/20249,340,000 shares $463.45 million -3.1%N/A20.1 $49.62
8/31/20249,640,000 shares $455.88 million -2.4%N/A20.5 $47.29
8/15/20249,880,000 shares $461.40 million -3.0%N/A20 $46.70
7/31/202410,180,000 shares $490.78 million +1.1%N/A19.7 $48.21
7/15/202410,070,000 shares $522.63 million +9.0%N/A18.3 $51.90
6/30/20249,240,000 shares $379.39 million -16.3%N/A16.9 $41.06
6/15/202411,040,000 shares $472.18 million +1.1%N/A19.8 $42.77
5/31/202410,920,000 shares $389.63 million +5.8%N/A19.7 $35.68
5/15/202410,320,000 shares $408.67 million -2.6%N/A18.7 $39.60
4/30/202410,590,000 shares $421.06 million +3.8%N/A17.5 $39.76
4/15/202410,200,000 shares $408.92 million +4.7%N/A17.1 $40.09
3/31/20249,740,000 shares $422.03 million +5.9%N/A15.4 $43.33
3/15/20249,200,000 shares $368 million +2.2%N/A13.7 $40.00
2/29/20249,000,000 shares $390.78 million +2.7%N/A12.3 $43.42
2/15/20248,760,000 shares $442.12 million -1.1%N/A11.7 $50.47
1/31/20248,860,000 shares $390.81 million +4.9%N/A11.6 $44.11
1/15/20248,450,000 shares $343.75 million +3.8%N/A11.7 $40.68
12/31/20238,140,000 shares $374.20 million -5.8%N/A11.5 $45.97
12/15/20238,640,000 shares $407.81 million -6.6%N/A13.2 $47.20
11/30/20239,250,000 shares $309.23 million -1.7%N/A15.2 $33.43
11/15/20239,410,000 shares $301.78 million -19.2%N/A16.5 $32.07
10/31/202311,650,000 shares $269.23 million -1.2%23.2%19.9 $23.11
10/15/202311,790,000 shares $294.51 million +16.9%23.6%17.3 $24.98
9/30/202310,090,000 shares $231.31 million -15.8%20.2%14.6 $22.93
9/15/202311,980,000 shares $299.02 million +12.5%24.0%16.8 $24.96
8/31/202310,650,000 shares $277.01 million -2.8%21.3%13.3 $26.01
8/15/202310,960,000 shares $287.04 million -11.7%22.0%13.7 $26.19
7/31/202312,410,000 shares $221.39 million +8.1%N/A16.1 $17.84
7/15/202311,480,000 shares $182.88 million +4.4%N/A16.2 $15.93
6/30/202311,000,000 shares $181.39 million +10.8%N/A15.4 $16.49
6/15/20239,930,000 shares $181.52 million +2.5%N/A13.6 $18.28
5/31/20239,690,000 shares $161.44 million +8.0%N/A15.2 $16.66
5/15/20238,970,000 shares $151.50 million +6.0%N/A12.7 $16.89
4/30/20238,460,000 shares $170.64 million +3.6%N/A12.7 $20.17
4/15/20238,170,000 shares $158.50 million +1.6%N/A13 $19.40
3/31/20238,040,000 shares $143.43 million +8.9%N/A12.5 $17.84
3/15/20237,380,000 shares $134.54 million -9.0%15.0%12.1 $18.23
2/28/20238,110,000 shares $197.15 million -0.4%16.6%13.2 $24.31
2/15/20238,140,000 shares $214.57 million +5.2%16.8%15 $26.36
1/31/20237,740,000 shares $211.69 million -2.4%16.0%12.9 $27.35
1/15/20237,930,000 shares $247.81 million +1.2%16.4%12.7 $31.25
12/30/20227,840,000 shares $228.30 million -3.1%16.2%12.5 $29.12
12/15/20228,090,000 shares $228.95 million +2.8%16.7%11.7 $28.30
11/30/20227,870,000 shares $210.68 million -6.8%16.3%7.9 $26.77
11/15/20228,440,000 shares $222.14 million +0.5%17.4%8 $26.32
10/31/20228,400,000 shares $211.43 million +10.2%17.4%7.4 $25.17
10/15/20227,620,000 shares $169.24 million -0.1%15.8%5.6 $22.21
9/30/20227,630,000 shares $186.94 million +26.5%16.1%3.1 $24.50
9/15/20226,030,000 shares $140.56 million +3.8%12.7%2.4 $23.31
Trump’s secret China deal (Ad)

Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors? Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all.tc pixel

Watch the full documentary and see which assets are positioned to benefit
8/31/20225,810,000 shares $131.31 million +3.8%13.4%2.3 $22.60
8/15/20225,600,000 shares $148.12 million -22.7%13.0%2.3 $26.45
7/31/20227,240,000 shares $91.22 million +21.9%16.9%3.1 $12.60
7/15/20225,940,000 shares $59.46 million +87.4%13.8%2.8 $10.01
6/30/20223,170,000 shares $13.16 million -13.6%7.4%3.2 $4.15
6/15/20223,670,000 shares $12.66 million +2.2%8.5%4.2 $3.45
5/31/20223,590,000 shares $12.35 million +15.8%8.4%6.8 $3.44
5/15/20223,100,000 shares $10.04 million -9.4%7.2%5.8 $3.24
4/30/20223,420,000 shares $21.41 million -7.3%8.0%6.2 $6.26
4/15/20223,690,000 shares $32.66 million -1.6%8.6%6.6 $8.85
3/31/20223,750,000 shares $43.20 million -22.2%8.7%6.5 $11.52
3/15/20224,820,000 shares $47.09 million +5.7%11.2%8.7 $9.77
2/28/20224,560,000 shares $34.75 million +4.4%10.6%9 $7.62
2/15/20224,370,000 shares $29.67 million +5.6%10.2%9 $6.79
1/31/20224,140,000 shares $30.68 million +5.1%9.7%10.9 $7.41
1/15/20223,940,000 shares $35.58 million +1.0%9.2%11.4 $9.03
12/31/20213,900,000 shares $38.92 million +2.1%9.1%11.4 $9.98
12/15/20213,820,000 shares $38.89 million +3.0%8.9%11 $10.18
11/30/20213,710,000 shares $33.20 million -1.3%8.7%12.4 $8.95
11/15/20213,760,000 shares $49.74 million -3.8%8.8%13.4 $13.23
10/29/20213,910,000 shares $45.00 million +0.3%9.1%14.3 $11.51
10/15/20213,900,000 shares $44.11 million +4.8%9.1%13 $11.31
9/30/20213,720,000 shares $48.58 million -0.3%8.7%13 $13.06
9/15/20213,730,000 shares $46.92 million -9.7%8.7%11.6 $12.58
8/31/20214,130,000 shares $53.73 million -6.1%9.6%11.7 $13.01
8/13/20214,400,000 shares $60.98 million -7.6%10.3%11.8 $13.86
7/30/20214,760,000 shares $82.30 million +9.2%11.1%12.6 $17.29
7/15/20214,360,000 shares $82.45 million +15.3%10.3%13.1 $18.91
6/30/20213,780,000 shares $74.01 million -1.6%9.0%10.7 $19.58

RYTM Short Interest - Frequently Asked Questions

Short interest is the volume of Rhythm Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 29th, traders have sold 7,911,004 shares of RYTM short. 12.27% of Rhythm Pharmaceuticals' shares are currently sold short. Learn More on Rhythm Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RYTM shares currently have a short interest ratio of 14.8. Learn More on Rhythm Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.27% of Rhythm Pharmaceuticals' floating shares are currently sold short.

Rhythm Pharmaceuticals saw a decrease in short interest in the month of May. As of May 29th, there was short interest totaling 7,911,004 shares, a decrease of 4.5% from the previous total of 8,282,367 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

12.27% of Rhythm Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Rhythm Pharmaceuticals: BioNTech SE Sponsored ADR (1.10%), Roivant Sciences Ltd. (5.65%), Insmed, Inc. (9.02%), Moderna, Inc. (16.33%), Viatris Inc. (3.54%), Genmab A/S Sponsored ADR (1.64%), BridgeBio Pharma, Inc. (14.52%), Ascendis Pharma A/S (4.60%), Axsome Therapeutics, Inc. (7.57%), Elanco Animal Health Incorporated (6.71%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling RYTM is an investing strategy that aims to generate trading profit from Rhythm Pharmaceuticals as its price is falling. RYTM shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Rhythm Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RYTM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RYTM, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like RYTM:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:RYTM) was last updated on 6/16/2026 by MarketBeat.com Staff.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel